Immunic Inc. (IMUX) Tops Q3 EPS by 4c

Immunic Inc. (NASDAQ: IMUX) reported Q3 EPS of ($0.51), $0.04 better than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Shutterstock CEO Paul Hennessy steps down; CFO named interim chief
• DHT Holdings Q2 TCE earnings estimated at $126,700 per day